Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-14

Clinical Trial Update: Use of Red Cell Distribution Width for Prediction of New-onset Atrial Fibrillation in Critically Ill Sepsis Patients

View source ↗

Summary

A completed clinical trial evaluated whether red cell distribution width can predict new-onset atrial fibrillation in critically ill patients with sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ain Shams University | Conditions: Atrial Fibrillation New Onset | Status: COMPLETED